Maria Digennaro is an expert in Oncology at Istituto Tumori Bari (Italy). Maria Digennaro has authored 34 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 55 (community average: 125). How the SLR is computed.

LeadR Profile

Maria Digennaro Istituto Tumori Bari Italy
55 ScienceLeadR Reputation 55
Network Map

Oncology

Subspecialties: Biochemistry - Endocrinology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2017 - 2026

Source: PubMed

Istituto Tumori Bari

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 34

Citations

Citations: 577 1st author: 1 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.
PMID 42218652 — breast neoplasms, neoplasms, carcinoma, intraductal, noninfiltrating, breast, therapeutics, wounds and injuries, tamoxifen
J Clin Oncol Top journal20260
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase III trial in non-invasive breast cancer.
PMID 40880294 — breast neoplasms, neoplasms, breast, tamoxifen
J Natl Cancer Inst20251
BRCA cascade counselling and testing in Italy: current position and future directions.
PMID 40596937 — research design, communication, neoplasms, psychological distress, counseling
BMC Cancer20250
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.
PMID 40293268 — breast neoplasms, incidence, estradiol, neoplasms, biomarkers, hormones, carcinoma, intraductal, noninfiltrating, insulin-like growth factor binding protein 3, insulin-like growth factor binding proteins, breast, therapeutics, tamoxifen
Clin Cancer Res20251
Case report: Germline mutation in a patient with GIST and lung adenocarcinoma.
PMID 39156708 — genes, lung, gastrointestinal stromal tumors, melanoma, neoplasms, adenocarcinoma, adenocarcinoma of lung, germ-line mutation, lung neoplasms, mutation
Front Oncol20241

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 3 1

By status:

Active not recruiting 1
Completed 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map